Gho Johannes M I H, van Es René, Stathonikos Nikolas, Harakalova Magdalena, te Rijdt Wouter P, Suurmeijer Albert J H, van der Heijden Jeroen F, de Jonge Nicolaas, Chamuleau Steven A J, de Weger Roel A, Asselbergs Folkert W, Vink Aryan
Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands.
Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
PLoS One. 2014 Apr 14;9(4):e94820. doi: 10.1371/journal.pone.0094820. eCollection 2014.
Myocardial fibrosis can lead to heart failure and act as a substrate for cardiac arrhythmias. In dilated cardiomyopathy diffuse interstitial reactive fibrosis can be observed, whereas arrhythmogenic cardiomyopathy is characterized by fibrofatty replacement in predominantly the right ventricle. The p.Arg14del mutation in the phospholamban (PLN) gene has been associated with dilated cardiomyopathy and recently also with arrhythmogenic cardiomyopathy. Aim of the present study is to determine the exact pattern of fibrosis and fatty replacement in PLN p.Arg14del mutation positive patients, with a novel method for high resolution systematic digital histological quantification of fibrosis and fatty tissue in cardiac tissue. Transversal mid-ventricular slices (n = 8) from whole hearts were collected from patients with the PLN p.Arg14del mutation (age 48±16 years; 4 (50%) male). An in-house developed open source MATLAB script was used for digital analysis of Masson's trichrome stained slides (http://sourceforge.net/projects/fibroquant/). Slides were divided into trabecular, inner and outer compact myocardium. Per region the percentage of connective tissue, cardiomyocytes and fatty tissue was quantified. In PLN p.Arg14del mutation associated cardiomyopathy, myocardial fibrosis is predominantly present in the left posterolateral wall and to a lesser extent in the right ventricular wall, whereas fatty changes are more pronounced in the right ventricular wall. No difference in distribution pattern of fibrosis and adipocytes was observed between patients with a clinical predominantly dilated and arrhythmogenic cardiomyopathy phenotype. In the future, this novel method for quantifying fibrosis and fatty tissue can be used to assess cardiac fibrosis and fatty tissue in animal models and a broad range of human cardiomyopathies.
心肌纤维化可导致心力衰竭,并成为心律失常的基础。在扩张型心肌病中可观察到弥漫性间质反应性纤维化,而致心律失常性心肌病的特征是主要在右心室出现纤维脂肪替代。受磷蛋白(PLN)基因中的p.Arg14del突变与扩张型心肌病有关,最近也与致心律失常性心肌病有关。本研究的目的是通过一种用于心脏组织中纤维化和脂肪组织高分辨率系统数字组织学定量的新方法,确定PLN p.Arg14del突变阳性患者中纤维化和脂肪替代的确切模式。从PLN p.Arg14del突变患者(年龄48±16岁;4例(50%)男性)的全心脏收集横向心室中部切片(n = 8)。使用内部开发的开源MATLAB脚本对Masson三色染色切片进行数字分析(http://sourceforge.net/projects/fibroquant/)。切片分为小梁、内层和外层致密心肌。对每个区域的结缔组织、心肌细胞和脂肪组织的百分比进行定量。在PLN p.Arg14del突变相关的心肌病中,心肌纤维化主要存在于左后外侧壁,在右心室壁中程度较轻,而脂肪变化在右心室壁中更明显。在临床主要表现为扩张型和致心律失常性心肌病表型的患者之间,未观察到纤维化和脂肪细胞分布模式的差异。未来,这种用于纤维化和脂肪组织定量的新方法可用于评估动物模型和广泛的人类心肌病中的心脏纤维化和脂肪组织。